07/03/2024 - Institutional news
The association presented its grants today. 44 projects will benefit from an investment of more than 13.4 million euros.
06/03/2024 - Press release
Between 1990 and 2019, the incidence of myocardial infarction in the Girona area decreased by 1% in women and 4% in men each year in the population aged 35 to 74 years, while, in the last 10 years, its lethality, the number of people who die 28 days after the onset of symptoms, has remained stagnant at around 15%. Data from almost five million hospital admissions and more than 70,000 death certificates have been analyzed as part of the REGICOR study, Registre Gironí del COR. These data suggest that primary prevention and rapidity of care have contributed to reducing the incidence of infarction and sudden death, increasing the chances of survival among patients arriving at the hospital.
Més informació "Decline in the mortality rate of people who suffer myocardial infarction stalls"
28/02/2024 - Covid-19
One of them is related to heart disease, according to the CARGENCORS study. The work has allowed finding a significant association of new genetic variants previously related to heart disease, thrombosis, inflammation, with the severity of COVID-19 in more than 3000 COVID-19 patients in the area of Barcelona and Girona. People with these variants have a 10-60% increased chance of developing severe disease. The CARGENCORS (CARdiovascular GENEtic risk score for Risk Stratification of patients positive for SARS-CoV-2 (COVID-19) virus) study has established a direct link between some of the genetic factors that increase the risk of heart disease and the severity of COVID-19. The work, published in the Journal of Medical Virology, marks a further step towards understanding the mechanisms of COVID-19 severity through susceptibility in heart disease.
Més informació "New genetic variants related to severe COVID-19 identified"
26/02/2024 - Institutional news
This is a project funded by the European Union that aims to promote positive physical and mental health in the workplace in a changing environment. The Hospital del Mar Research Institute leads the PROSPERH project in the State, an initiative financed by EU-Horizon Europe, and formed by an international consortium of 21 partners from 19 countries. They will work together to develop and validate a multilevel intervention, aimed at work organizational aspects, individuals and their peers, the workers. It has three components focused on health promotion, self-management and online self-management, and indication of appropriate clinical care referral pathways.
23/02/2024 - Institutional news
A collaborative effort led by Dr. Anna Bigas, from the Hospital del Mar Research Institute and Josep Carreras Leukaemia Research Institute, found that the population of haematopoietic stem cells (HSC) responsible for the generation and self-renewal of the blood and immune system keeps a long-term undifferentiated state thanks to its ability to physically block its own NOTCH1 receptor through the expression of JAGGED1, a specific NOTCH activator. Authors hypothesise that the lack of this previously unknown mechanism might be the cause for the poor performance of current approaches to generate HSC from induced pluripotent stem cells for regenerative medicine.
21/02/2024 - Press release
This is an international collaborative work coordinated by the Hospital del Mar Research Institut and the Hospital Clínic-IDIBAPS, published in the Journal of Neurology. This new tool may make it possible to adapt the monitoring and treatment of patients to their future evolution, opting for the most effective, but with more possible side effects in those with worse prognosis. The exact factors behind the progression of disability in multiple sclerosis, a disease with great heterogeneity, are unknown, which is why it is so important to have tools of this type.
20/02/2024 - General information
He does so as a Reference Researcher, the highest possible category. A fact that recognizes his research activity in recent years. Dr. Daniel Guinart, consultant psychiatrist at the Psychosocial Rehabilitation and Treatment-Resistant Schizophrenia Unit of the Hospital del Mar and researcher at its research institute, has achieved the category of Reference Researcher of the Sociedad Española de Psiquiatría y Salud Mental (SEPSM). This recognition of his work is part of the Research Excellence Program of the organization.
19/02/2024 - General information
The Ministry of Science, Innovation and Universities and the European Union, through the Next Generation EU program will finance this new phase. It will evaluate the efficacy of CTH120 as an innovative therapy in adult patients with SXF, the most common form of hereditary intellectual disability without specific treatment. The public-private consortium formed by the biotechnology company CONNECTA Therapeutics, the Hospital del Mar Research Institute, the Center for Genomic Regulation (CRG), and the Parc Taulí Research and Innovation Institute (I3PT) will receive 2,7 million euros in funding from the Ministry of Science, Innovation and Universities and the European Union, through the Next Generation EU program, to initiate Phase IIa clinical trials of the drug CTH120 for the treatment of Fragile X syndrome (Fragile X syndrome).
Més informació "Nearly 3 million euros to initiate Phase IIa of CTH120 drug for Fragile X syndrome"
16/02/2024 - Events
From March 4 to May 13, 2024, will take place in different libraries of Barcelona the cycle "What do we know about heart diseases", organized by Hospital del Mar Research Institute and the Network of Libraries of Barcelona. This is a cycle that is part of the "Visions of Science" project that the Barcelona Libraries have been carrying out for years, and that for the fourth year has been entrusted to the Hospital del Mar Research Institute thanks to the success obtained in previous editions.
15/02/2024 - Press release
A study by Hospital del Mar and Hospital General de Catalunya shows that this new type of device is three times more effective than previous models in completely closing the aneurysm. Moreover, in a safe way. It is published in the Journal of Neurointerventional Surgery. The new generation of stents for the treatment of cerebral aneurysms is more effective and safer, according to a study by Hospital del Mar and Hospital General de Catalunya that has just been published in the Journal of Neurointerventional Surgery. In fact, they are three times more effective, with practically no complications.
Més informació "Efficacy of the new generation of stents to treat cerebral aneurysm validated"
Servei de Comunicació:
Marta Calsina Freixas(ELIMINAR)
Tel:
(+34) 93 316 06 80
Doctor Aiguader, 88
08226 Barcelona
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
